<p>A, Western blot analysis to assess Stat-1 activation after 12 min stimulation with IFNγ (1000 U/ml), in presence or absence of BXL-01-0029 (10<sup>−8</sup> M) showed that IFNγ increased Stat-1 phosphorylation, whereas BXL-01-0029 did not exert any effect (upper A); total Stat-1 was used as loading control (middle A). The densitometric analysis is reported in lower A (*P<0.05 vs. control) and results are expressed as ratio phosporylated/total protein arbitrary units vs. IFNγ-treated cells, taken as 1 (mean±S.E.). B, Cell incubation for 24 h with BXL-01-0029 (10<sup>−8</sup> M) did not affect IFNγ-induced CXCL10 secretion, taken as 100%. Results (mean±S.E.) are derived from five experiments, using distinct cell preparations.</p
<p>Cells were treated with the combination of IFN-γ (100 ng/mL) and TNF-α (10 ng/mL) for indicated t...
<p>(A) MCF10DCIS cells were treated with BXL0124 (10 nM) for 24 h. Cells were fixed using 4% parafor...
<p>(A) CD100 expression on CD5+ and CD5- B cells from one representative, healthy donor before and a...
<p>A, Immunocytochemistry revealed no constitutive expression of class I and class II HLA in control...
<p>Following starvation for 18 hours, dermal fibroblasts from NOD (open bars) and C57BL/6 (solid bar...
<p>(A) Western blot analysis showing a representative experiment of SF-E pretreatment on IFNγ-induce...
<p>NIT-1 cells were treated with IFN-γ (100 ng/mL) or TNF-α (10 ng/mL) alone or in combination for 1...
<p>NPCs were treated with 100 ng/ml IFNγ for different times and analyzed as described in <a href="h...
<p>Cells were transfected with individual plasmid constructs of either STAT1-GFP, STAT1-CC-GFP, or S...
<p>A, CXCL10 secretion, virtually absent in control, was significantly increased by 24γ (1000 U/ml) ...
<p>BEAS-2B cells were pre-treated for 1h with either PF956980 or PF1367550 followed by stimulation f...
<p>A, <i>WT</i> and <i>STAT1<sup>−/−</sup></i> VSMCs were treated with 10 ng/ml IFNγ for 8 h or with...
<p>WISH cells were treated with either 200 nM antagonist or 1 nM YNS for 30 minutes and analyzed for...
<p>A, BXL-01-0029 (open triangles), elocalcitol (closed triangles), MTX (open squares), CsA (closed ...
<p>(A). MDM were treated with different doses of IFN-α for 24 hours, then p-STAT1 (Tyr 701), STAT1, ...
<p>Cells were treated with the combination of IFN-γ (100 ng/mL) and TNF-α (10 ng/mL) for indicated t...
<p>(A) MCF10DCIS cells were treated with BXL0124 (10 nM) for 24 h. Cells were fixed using 4% parafor...
<p>(A) CD100 expression on CD5+ and CD5- B cells from one representative, healthy donor before and a...
<p>A, Immunocytochemistry revealed no constitutive expression of class I and class II HLA in control...
<p>Following starvation for 18 hours, dermal fibroblasts from NOD (open bars) and C57BL/6 (solid bar...
<p>(A) Western blot analysis showing a representative experiment of SF-E pretreatment on IFNγ-induce...
<p>NIT-1 cells were treated with IFN-γ (100 ng/mL) or TNF-α (10 ng/mL) alone or in combination for 1...
<p>NPCs were treated with 100 ng/ml IFNγ for different times and analyzed as described in <a href="h...
<p>Cells were transfected with individual plasmid constructs of either STAT1-GFP, STAT1-CC-GFP, or S...
<p>A, CXCL10 secretion, virtually absent in control, was significantly increased by 24γ (1000 U/ml) ...
<p>BEAS-2B cells were pre-treated for 1h with either PF956980 or PF1367550 followed by stimulation f...
<p>A, <i>WT</i> and <i>STAT1<sup>−/−</sup></i> VSMCs were treated with 10 ng/ml IFNγ for 8 h or with...
<p>WISH cells were treated with either 200 nM antagonist or 1 nM YNS for 30 minutes and analyzed for...
<p>A, BXL-01-0029 (open triangles), elocalcitol (closed triangles), MTX (open squares), CsA (closed ...
<p>(A). MDM were treated with different doses of IFN-α for 24 hours, then p-STAT1 (Tyr 701), STAT1, ...
<p>Cells were treated with the combination of IFN-γ (100 ng/mL) and TNF-α (10 ng/mL) for indicated t...
<p>(A) MCF10DCIS cells were treated with BXL0124 (10 nM) for 24 h. Cells were fixed using 4% parafor...
<p>(A) CD100 expression on CD5+ and CD5- B cells from one representative, healthy donor before and a...